Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.06 - Poster Session 1 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 59
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.06-017 - Targeted proteomics and HT-IHC for lung cancer biomarker studies.
09:30 - 09:30 | Author(s): Y.J. Kim
- Abstract
Loading... -
+
P1.06-032 - The high protein expression of EGFR using a specific internal domain antibody and loss of PTEN can be used as predictive factors for EGFR TKIs in patients with advanced squamous cell lung cancer
09:30 - 09:30 | Author(s): J. Oh
- Abstract
Loading...
-
+
P1.07 - Poster Session 1 - Surgery
- Type: Poster Session
- Track: Surgery
- Presentations: 48
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.07-030 - Prognostic factors for patients in brain metastasis with no extracranial metastasis after resection of non-small cell lung cancer
09:30 - 09:30 | Author(s): M.K. Bae
- Abstract
Loading...
-
+
P1.09 - Poster Session 1 - Combined Modality
- Type: Poster Session
- Track: Combined Modality
- Presentations: 22
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.09-005 - The optimal timing of SRS add to EGFR-TKI treatment for brain metastasis from activating EGFR mutant NSCLC
09:30 - 09:30 | Author(s): H.J. Kim
- Abstract
Loading...
-
+
P1.10 - Poster Session 1 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 57
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.10-003 - Alteration of the E-cadherin/β-catenin complex predicts poor response to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment
09:30 - 09:30 | Author(s): S.B. Yoo
- Abstract
Loading... -
+
P1.10-026 - Validation of EGFR Mutation Testing Using Cytology Specimens in Non-small Cell Lung Carcinoma: Multi-institutional study of 128 cases in Korea
09:30 - 09:30 | Author(s): K. Min
- Abstract
Loading...
-
+
P1.11 - Poster Session 1 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 45
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.11-015 - The prognostic value of total number of harvested lymph nodes and nodal ratio in node positive Non-small cell lung cancer
09:30 - 09:30 | Author(s): J. Kim
- Abstract
Loading... -
+
P1.11-024 - A phase I/II randomized trial using GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) vaccine plus or minus CCL21 in stage IV lung adenocarcinoma: Updated results
09:30 - 09:30 | Author(s): J.E. Gray
- Abstract
Loading... -
+
P1.11-027 - Phase I studies of HM781-36B, an irreversible pan-HER tyrosine kinase inhibitor (TKI) in patients with advanced solid tumor and the therapeutic potential in patients with advanced non-small cell lung cancer (NSCLC)
09:30 - 09:30 | Author(s): D. Kim
- Abstract
Loading...
-
+
P1.18 - Poster Session 1 - Pathology
- Type: Poster Session
- Track: Pathology
- Presentations: 22
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.18-004 - The Relationship Between EGFR Mutations and the Clinicopathologic Features of Lung Adenocarcinomas Diagnosed by the Small Biopsies
09:30 - 09:30 | Author(s): K. Shin
- Abstract
Loading...
-
+
MO06 - NSCLC - Chemotherapy I
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 14
- Moderators:R. Perez-Soler
- Coordinates: 10/28/2013, 16:15 - 17:45, Parkside Ballroom A, Level 1
-
+
MO06.01 - Clinical features of patients with non small cell lung cancer who harbor EGFR mutation and present with miliary intrapulmonary or disseminated carcinomatosis
16:15 - 16:20 | Author(s): H.J. Kim
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO07 - NSCLC - Targeted Therapies II
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 14
- Moderators:T. John
- Coordinates: 10/28/2013, 16:15 - 17:45, Bayside Auditorium B, Level 1
-
+
MO07.08 - The frequency and impact of ROS1-rearrangement on clinical outcomes in never-smokers with lung adenocarcinoma
16:55 - 17:00 | Author(s): S.M. Lim
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO10 - Molecular Pathology II
- Type: Mini Oral Abstract Session
- Track: Pathology
- Presentations: 13
- Moderators:W.A. Franklin
- Coordinates: 10/28/2013, 16:15 - 17:45, Bayside 104, Level 1
-
+
MO10.01 - Integrative and comparative genomic analysis of East-Asian lung squamous cell carcinomas
16:15 - 16:20 | Author(s): Y. Kim
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.09 - Poster Session 2 - Combined Modality
- Type: Poster Session
- Track: Combined Modality
- Presentations: 18
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.09-015 - Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small cell lung cancer: A propensity score matching analysis
09:30 - 09:30 | Author(s): H.J. Kim
- Abstract
Loading...